Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 350852, 6 pages
http://dx.doi.org/10.1155/2012/350852
Clinical Study

Plasma Plasminogen Activator Inhibitor-1 Is Associated with End-Stage Proliferative Diabetic Retinopathy in the Northern Chinese Han Population

1Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China
2Center of Vitreoretinopathy, Tianjin Eye Hospital, Tianjin 300020, China

Received 26 June 2012; Revised 2 September 2012; Accepted 9 October 2012

Academic Editor: D. R. Webb

Copyright © 2012 Ze-Long Zhong and Song Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Sieu, W. Katon, E. H. B. Lin, J. Russo, E. Ludman, and P. Ciechanowski, “Depression and incident diabetic retinopathy: a prospective cohort study,” General Hospital Psychiatry, vol. 33, no. 5, pp. 429–435, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Stevens, K. P. Truesdale, E. G. Katz, and J. Cai, “Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: The People's Republic of China study and the atherosclerosis risk in communities study,” American Journal of Epidemiology, vol. 167, no. 11, pp. 1365–1374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Y. H. Wong, P. Poon, C. C. Szeto, J. C. N. Chan, and P. K. T. Li, “Association of plasminogen activator inhibitor-1 4G/4G genotype and type 2 diabetic nephropathy in Chinese patients,” Kidney International, vol. 57, no. 2, pp. 632–638, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Li, S. Liu, L. Miao, and L. Cai, “Prevention of diabetic complications by activation of Nrf2: diabetic cardiomyopathy and nephropathy,” Experimental Diabetes Research, vol. 2012, Article ID 216512, 7 pages, 2012. View at Google Scholar
  5. A. Gumieniczek, B. Owczarek, and B. Pawlikowska, “Oxidative/ nitrosative stress and protein damages in aqueous humor of hyperglycemic rabbits: effects of two oral antidiabetics, pioglitazone and repaglinide,” Experimental Diabetes Research, vol. 2012, Article ID 653678, 2012. View at Google Scholar
  6. M. Y. Chun, H. S. Hwang, H. Y. Cho et al., “Association of vascular endothelial growth factor polymorphisms with nonproliferative and proliferative diabetic retinopathy,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 7, pp. 3547–3551, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Galetović, D. Karlica, K. Bućan, and L. Znaor, “The role of clinical and metabolic factors in the genesis and development of diabetic retinopathy,” Acta Medica Croatica, vol. 62, no. 1, pp. 23–27, 2008. View at Google Scholar · View at Scopus
  8. J. Esteves, A. F. Laranjeira, M. F. Roggia et al., “Diabetic retinopathy risk factors,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 52, no. 3, pp. 431–441, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. L. Zhong, M. Han, and S. Chen, “Risk factors associated with retinal neovascularization of diabetic retinopathy in type 2 diabetes mellitus,” International Journal of Ophthalmology, vol. 4, no. 2, pp. 182–185, 2011. View at Google Scholar
  10. H. A. Van Leiden, J. M. Dekker, A. C. Moll et al., “Risk factors for incident retinopathy in a diabetic and nondiabetic population: The Hoorn study,” Archives of Ophthalmology, vol. 121, no. 2, pp. 245–251, 2003. View at Google Scholar · View at Scopus
  11. T. C. Rodrigues, M. Pecis, M. J. Azevedo, and J. L. Gross, “Blood pressure homeostasis and microvascular complications in diabetic patients,” Arquivos Brasileiros de Endocrinologia e Metabologia, vol. 49, no. 6, pp. 882–890, 2005. View at Google Scholar · View at Scopus
  12. X. L. Cai, F. Wang, and L. N. Ji, “Risk factors of diabetic retinopathy in type 2 diabetic patients,” Chinese Medical Journal, vol. 119, no. 10, pp. 822–826, 2006. View at Google Scholar · View at Scopus
  13. C. B. Leitão, L. H. Canani, S. P. Silveiro, and J. L. Gross, “Ambulatory blood pressure monitoring and type 2 diabetes mellitus.,” Arquivos Brasileiros de Cardiologia, vol. 89, no. 5, pp. 315–354, 2007. View at Google Scholar · View at Scopus
  14. X. W. Xie, L. Xu, Y. X. Wang, and J. B. Jonas, “Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 11, pp. 1519–1526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Li and Y. H. Hu, “Susceptibility genes for diabetic retinopathy,” International Ophthalmology, vol. 2, no. 1, pp. 1–6, 2009. View at Google Scholar
  16. X. W. Xie, L. Xu, Y. X. Wang, and J. B. Jonas, “Prevalence and associated factors of diabetic retinopathy. The Beijing Eye Study 2006,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 11, pp. 1519–1526, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Yang, C. C. Sun, W. C. Ku et al., “Axial length and proliferative diabetic retinopathy,” Optometry & Vision Science, vol. 89, pp. 465–470, 2012. View at Google Scholar
  18. M. Follo and D. Ginsburg, “Structure and expression of the human gene encoding plasminogen activator inhibitor, PAI-1,” Gene, vol. 84, no. 2, pp. 447–453, 1989. View at Publisher · View at Google Scholar · View at Scopus
  19. S. F. Yan, D. J. Pinsky, N. Mackman, and D. M. Stern, “Egr-1: is it always immediate and early?” Journal of Clinical Investigation, vol. 105, no. 5, pp. 553–554, 2000. View at Google Scholar · View at Scopus
  20. H. Liao, M. C. Hyman, D. A. Lawrence, and D. J. Pinsky, “Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1α, and C/EBPα,” FASEB Journal, vol. 21, no. 3, pp. 935–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Kahn, “Report of the expert committee on the diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 20, no. 7, pp. 1183–1197, 1997. View at Google Scholar · View at Scopus
  22. R. Klein, M. D. Knudtson, K. E. Lee, R. Gangnon, and B. E. K. Klein, “The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXII. The twenty-five-year progression of retinopathy in persons with type 1 diabetes,” Ophthalmology, vol. 115, no. 11, pp. 1859–1868, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. D. Davis, M. R. Fisher, R. E. Gangnon et al., “Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: early treatment diabetic retinopathy study report 18,” Investigative Ophthalmology and Visual Science, vol. 39, no. 2, pp. 233–252, 1998. View at Google Scholar · View at Scopus
  24. V. A. Koivisto, L. K. Stevens, M. Mattock et al., “Cardiovascular disease and its risk factors in IDDM in Europe,” Diabetes Care, vol. 19, no. 7, pp. 689–697, 1996. View at Google Scholar · View at Scopus
  25. L. Zhang, G. C. Curhan, F. B. Hu, E. B. Rimm, and J. P. Forman, “Association between passive and active smoking and incident type 2 diabetes in women,” Diabetes Care, vol. 34, no. 4, pp. 892–897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. T. Kruszynska, J. G. Yu, J. M. Olefsky, and B. E. Sobel, “Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects,” Diabetes, vol. 49, no. 4, pp. 633–639, 2000. View at Google Scholar · View at Scopus
  27. M. Ugajin, K. Yamaki, N. Iwamura, T. Yagi, and T. Asano, “Blood urea nitrogen to serum albumin ratio independently predicts mortality and severity of community- acquired pneumonia,” International Journal of General Medicine, vol. 5, pp. 583–589, 2012. View at Google Scholar
  28. J. Závada, E. Hoste, R. Cartin-Ceba et al., “A comparison of three methods to estimate baseline creatinine for RIFLE classification,” Nephrology Dialysis Transplantation, vol. 25, no. 12, pp. 3911–3918, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. G. T. C. Ko, H. P. S. Wai, and J. S. F. Tang, “Effects of age on plasma glucose levels in non-diabetic Hong Kong Chinese,” Croatian Medical Journal, vol. 47, no. 5, pp. 709–713, 2006. View at Google Scholar · View at Scopus
  30. S. Wang, L. Xu, J. B. Jonas, Y. X. Wang, Q. S. You, and H. Yang, “Dyslipidemia and eye diseases in the adult Chinese population: The Beijing Eye Study,” PLoS One, vol. 7, no. 3, article e26871, 2012. View at Google Scholar
  31. I. Ezzidi, N. Mtiraoui, M. Chaieb, M. Kacem, T. Mahjoub, and W. Y. Almawi, “Diabetic retinopathy, PAI-1 4G/5G and -844G/A polymorphisms, and changes in circulating PAI-1 levels in Tunisian type 2 diabetes patients,” Diabetes and Metabolism, vol. 35, no. 3, pp. 214–219, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. B. Meigs, J. Dupuis, C. Liu et al., “PAI-1 gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample,” Obesity, vol. 14, no. 5, pp. 753–758, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Brazionis, K. Rowley, A. Jenkins, C. Itsiopoulos, and K. O'Dea, “Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 4, pp. 786–791, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Tarnow, C. D. A. Stehouwer, J. J. Emeis et al., “Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy,” Nephrology Dialysis Transplantation, vol. 15, no. 5, pp. 625–630, 2000. View at Google Scholar · View at Scopus
  35. D. M. Hallman, J. C. Huber, V. H. Gonzalez, B. E. K. Klein, R. Klein, and C. L. Hanis, “Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas,” Diabetes Care, vol. 28, no. 5, pp. 1163–1168, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. Diabetes Control and Complications Trial Research Group, “Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial,” Diabetes, vol. 46, pp. 1829–1839, 1997. View at Google Scholar
  37. L. Zhang, G. C. Curhan, F. B. Hu, E. B. Rimm, and J. P. Forman, “Association between passive and active smoking and incident type 2 diabetes in women,” Diabetes Care, vol. 34, no. 4, pp. 892–897, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Bamashmus, A. Gunaid, and R. Khandekar, “Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study,” Indian Journal of Ophthalmology, vol. 57, no. 4, pp. 293–298, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. P. K. Rani, R. Raman, A. Chandrakantan, S. S. Pal, G. M. Perumal, and T. Sharma, “Risk factors for diabetic retinopathy in self-reported rural population with diabetes,” Journal of Postgraduate Medicine, vol. 55, no. 2, pp. 92–96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. I. P. Chatziralli, T. N. Sergentanis, P. Keryttopoulos, N. Vatkalis, A. Agorastos, and L. Papazisis, “Risk factors associated with diabetic retinopathy in patients with diabetes mellitus type 2,” BMC Research Notes, vol. 3, pp. 153–156, 2010. View at Publisher · View at Google Scholar · View at Scopus